Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.10 (0.44%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £234.54m
SCLP Live PriceLast checked at - London Stock Exchange

Intraday Scancell Holdings Share Chart

Scancell Holdings News

Scancell reports strong results from Immunobody trial
7 Nov 2025

Scancell reports strong results from Immunobody trial

(Sharecast News) - Scancell Holdings reported strong phase two results for its Immunobody iSCIB1+ cancer immunotherapy on Friday, showing significant ...

TRADING UPDATES: Gfinity's Yentra partners with ESG Institute
17 Sep 2025

TRADING UPDATES: Gfinity's Yentra partners with ESG Institute

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance...

Scancell narrows loss as it progresses immunotherapy pipeline
11 Sep 2025

Scancell narrows loss as it progresses immunotherapy pipeline

(Sharecast News) - Scancell reported progress across its immunotherapy pipeline on Thursday, as it narrowed annual losses and prepared for late-stage ...

Scancell Holdings notes "tough" macro-environment as loss widens
11 Sep 2025

Scancell Holdings notes "tough" macro-environment as loss widens

(Alliance News) - Scancell Holdings PLC on Thursday said it has made "strong progress" over the last 18 months, but noted impacts from the "tough macr...

TRADING UPDATES: Scancell reports positive data from melanoma trial
23 Jul 2025

TRADING UPDATES: Scancell reports positive data from melanoma trial

(Alliance News) - The following is a round-up of updates and earnings by London-listed companies, issued on Tuesday and not separately reported by All...

Scancell starts dosing next cohort in melanoma treatment study
25 Jun 2025

Scancell starts dosing next cohort in melanoma treatment study

(Sharecast News) - Scancell announced on Wednesday that it has started dosing patients in cohort four of its phase 2 'SCOPE' clinical trial, evaluatin...

Scancell partners with NHS to fast-track melanoma vaccine trial
14 Apr 2025

Scancell partners with NHS to fast-track melanoma vaccine trial

(Alliance News) - Scancell Holdings PLC on Monday said it has partnered with the NHS Cancer Vaccine Launch Pad, to accelerate patient recruitment into...